Safety and efficacy of a DKK1 inhibitor (DKN-01) in combination with pembrolizumab (P) in patients (Pts) with advanced gastroesophageal (GE) malignancies

S. J. Klempner, J. Bendell, V. Meucci Villaflor, L. Tenner, S. Stein, C. A. Sirard, W. Newman, M. Kagey, K. Schlienger, J. Strickler

Resultado de la investigación: Articlerevisión exhaustiva

Idioma originalEnglish (US)
Páginas (desde-hasta)viii222
PublicaciónAnnals of oncology : official journal of the European Society for Medical Oncology
Volumen29
DOI
EstadoPublished - oct. 1 2018

ASJC Scopus subject areas

  • Hematology
  • Oncology

Citar esto